FDA panel backs experimental Merck hepatitis drug
Wednesday, April 27, 2011 - 14:30
in Health & Medicine
WASHINGTON (AP) -- Federal health experts are recommending approval for a highly anticipated drug from Merck to treat hepatitis C, based on studies showing it cures patients at a higher rate than drugs used for over 20 years....